The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer

The dendritic cell (DC)‐T cell axis is a bridge that connects innate and adaptive immunities. The initial immune response against tumors is mainly induced by mature antigen‐presenting DCs. Enhancing the crosstalk between DCs and T cells may be an effective approach to improve the immune response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuangcui, Zhang, Guan, Cui, Qian, Yang, Yanjie, Wang, Dong, Liu, Aqing, Xia, Ying, Li, Wentao, Liu, Yunhe, Yu, Jianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681037/
https://www.ncbi.nlm.nih.gov/pubmed/38018578
http://dx.doi.org/10.1002/iid3.1099
_version_ 1785150755469000704
author Wang, Shuangcui
Zhang, Guan
Cui, Qian
Yang, Yanjie
Wang, Dong
Liu, Aqing
Xia, Ying
Li, Wentao
Liu, Yunhe
Yu, Jianchun
author_facet Wang, Shuangcui
Zhang, Guan
Cui, Qian
Yang, Yanjie
Wang, Dong
Liu, Aqing
Xia, Ying
Li, Wentao
Liu, Yunhe
Yu, Jianchun
author_sort Wang, Shuangcui
collection PubMed
description The dendritic cell (DC)‐T cell axis is a bridge that connects innate and adaptive immunities. The initial immune response against tumors is mainly induced by mature antigen‐presenting DCs. Enhancing the crosstalk between DCs and T cells may be an effective approach to improve the immune response to non‐small cell lung cancer (NSCLC). In this article, a review was made of the interaction between DCs and T cells in the treatment of NSCLC and how this interaction affects the treatment outcome.
format Online
Article
Text
id pubmed-10681037
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106810372023-11-27 The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer Wang, Shuangcui Zhang, Guan Cui, Qian Yang, Yanjie Wang, Dong Liu, Aqing Xia, Ying Li, Wentao Liu, Yunhe Yu, Jianchun Immun Inflamm Dis Review Articles The dendritic cell (DC)‐T cell axis is a bridge that connects innate and adaptive immunities. The initial immune response against tumors is mainly induced by mature antigen‐presenting DCs. Enhancing the crosstalk between DCs and T cells may be an effective approach to improve the immune response to non‐small cell lung cancer (NSCLC). In this article, a review was made of the interaction between DCs and T cells in the treatment of NSCLC and how this interaction affects the treatment outcome. John Wiley and Sons Inc. 2023-11-27 /pmc/articles/PMC10681037/ /pubmed/38018578 http://dx.doi.org/10.1002/iid3.1099 Text en © 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Wang, Shuangcui
Zhang, Guan
Cui, Qian
Yang, Yanjie
Wang, Dong
Liu, Aqing
Xia, Ying
Li, Wentao
Liu, Yunhe
Yu, Jianchun
The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
title The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
title_full The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
title_fullStr The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
title_full_unstemmed The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
title_short The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
title_sort dc–t cell axis is an effective target for the treatment of non‐small cell lung cancer
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681037/
https://www.ncbi.nlm.nih.gov/pubmed/38018578
http://dx.doi.org/10.1002/iid3.1099
work_keys_str_mv AT wangshuangcui thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT zhangguan thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT cuiqian thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT yangyanjie thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT wangdong thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT liuaqing thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT xiaying thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT liwentao thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT liuyunhe thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT yujianchun thedctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT wangshuangcui dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT zhangguan dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT cuiqian dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT yangyanjie dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT wangdong dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT liuaqing dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT xiaying dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT liwentao dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT liuyunhe dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer
AT yujianchun dctcellaxisisaneffectivetargetforthetreatmentofnonsmallcelllungcancer

Ejemplares similares